34 research outputs found

    An Induced Natural Selection Heuristic for Finding Optimal Bayesian Experimental Designs

    Get PDF
    Bayesian optimal experimental design has immense potential to inform the collection of data so as to subsequently enhance our understanding of a variety of processes. However, a major impediment is the difficulty in evaluating optimal designs for problems with large, or high-dimensional, design spaces. We propose an efficient search heuristic suitable for general optimisation problems, with a particular focus on optimal Bayesian experimental design problems. The heuristic evaluates the objective (utility) function at an initial, randomly generated set of input values. At each generation of the algorithm, input values are "accepted" if their corresponding objective (utility) function satisfies some acceptance criteria, and new inputs are sampled about these accepted points. We demonstrate the new algorithm by evaluating the optimal Bayesian experimental designs for the previously considered death, pharmacokinetic and logistic regression models. Comparisons to the current "gold-standard" method are given to demonstrate the proposed algorithm as a computationally-efficient alternative for moderately-large design problems (i.e., up to approximately 40-dimensions)

    Quasi-Birth-and-Death Processes with Rational Arrival Process Components

    Get PDF

    Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

    Get PDF
    IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

    Estimation and Control in ATM Networks

    No full text
    In this paper we consider the question of how to control an ATM network in the presence of incomplete source information. Such a network must use observation and estimation to attempt to fill, at least partially, the information void if it is to achieve a reasonable degree of efficiency. We consider estimation under these assumptions. Appealing to Dynamic Programming shows that there is no theoretical evidence to support the separation of estimation and control. This is because the problem does not fit in to the celebrated framework of a linear system with quadratic cost functional. Simple arguments show that estimation and control indeed can not be separated. We also use the Bayesian approach and show that Maximum Likelihood Estimation is an unsuitable method of estimation. The fact behind all these conclusions is the extreme non-linearity of the Quality of Service as a function of the source parameters. Keywords: Dynamic Programming, ATM Networks, Bayes Estimation 1 Introduction In..

    Stochastic 2-dimensional fluid model

    No full text

    Quasi-reversibility and quasi-birth-and-death processes

    No full text
    info:eu-repo/semantics/publishe

    Hitting probabilities and hitting times for stochastic fluid flows

    No full text
    Recently there has been considerable interest in Markovian stochastic fluid flow models. A number of authors have used different methods to calculate quantities of interest. In this paper, we consider a fluid flow model, formulated so that time is preserved, and derive expressions for return probabilities to the initial level, the Laplace-Stieltjes transforms (for arguments with nonnegative real part only) and moments of the time taken to return to the initial level, excursion probabilities to high/low levels, and the Laplace-Stieltjes transforms of sojourn times in specified sets. An important feature of our results is their physical interpretation within the stochastic fluid flow environment, which is given. This allows for further implementation of our expressions in the calculation of other quantities of interest. Novel aspects of our treatment include the calculation of probability densities with respect to level and an argument under which we condition on the infimum of the levels at which a "down-up period" occurs. Significantly, these results are achieved with techniques applied directly within the fluid flow model, without the need for discretization or transformation to other equivalent models.Markovian fluid model Hitting probabilities Hitting times Sojourn times
    corecore